This Blanket Purchase Agreement awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 provides for the delivery of radiometer blood gas testing reagents on two separate occasions. Radiometer America, Inc. is the prime contractor obligated to deliver $39,171.63 worth of reagents by January 31, 2023 and an additional $22,786.94 worth of reagents by August 24, 2022. Both orders are firm fixed price and contain reagents to support blood...
The Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) contract to Polyscientific Research and Development Corporation, a leading manufacturer of chemicals, stains, and reagents for in vitro diagnostic testing. The $8 million BPA contract, with a period of performance through September 2026, provides the agency with an efficient mechanism to procure a wide range of reagents and consumable supplies to support its medical testing and research programs. Specific...
The Department of the Air Force Air Combat Command awarded a single award blanket purchase agreement to Ortho-Clinical Diagnostics Inc. to procure chemistry reagents in support of research programs at Davis-Monthan Air Force Base. The potential value of the agreement is $700,000 with pricing updated annually per the vendor's price list. Reagents for the Vitros 5600 analyzer listed in the performance work statement appendix will be provided through August 31, 2026. A firm fixed price task order...
The Department of the Navy Bureau of Medicine and Surgery has awarded Alere San Diego, Inc. dba Immunalysis Corporation, a subsidiary of Abbott Laboratories Inc., a single-award indefinite delivery contract for the procurement of OXYCODONE & OXYMORPHONE REAGENT KITS. This $907,680.00 contract, awarded on February 15, 2024, supports the acquisition of immunoassay reagents, test kits, calibrators, and controls to detect and quantify substances like fentanyl, norfentanyl, and synthetic...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The 5-year, single-award contract has a ceiling value of $303,372.63 and does not use any set-aside designations. Through this BPA, the VA can acquire essential medical equipment, reagents, and...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Fisher Scientific Company L.L.C., Fisher Healthcare Division, to provide micro reagents and consumables. The single-award, firm-fixed-price contract has a total ceiling value of $4,098,246.88 and is set to run through September 30, 2028. Under this IDC, the VA has issued a $369,858.16 delivery order for micro reagents and consumables to support the Richmond VA Medical Center. The contracted items include...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 1 (VISN1), has awarded a single-award Blanket Purchase Agreement (BPA) to Fisher Scientific Company L.L.C. (doing business as Fisher Scientific) for the delivery of GENEXUS REAGENTS. The $6,381,461.95 BPA, which has a period of performance from February 1, 2025, to January 31, 2030, will serve as an indefinite delivery vehicle (IDV) for the VA to procure specialized reagents, supplies, and equipment required for its...
Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded an indefinite delivery contract by the Defense Health Agency to provide immunochemistry reagents. The contract has a potential value of $3.78 million and a period of performance through September 2023. Task orders issued to date include a $1.4 million order for the Defense Health Agency and orders valued at $1.89 million and $1.2 million for the Department of the Army Medical Command. Performance will take...
This indefinite delivery contract was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostics, laboratory instruments, reagents, and associated products and services. The $6 million single-award IDC, which runs through September 2014, enables the FDA to acquire Roche's reagents, test kits, and other medical equipment and consumables on an as-needed basis through a series of fixed-price delivery...